• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle.

作者信息

Massimi P, Banks L

机构信息

International Centre for Genetic Engineering and Biotechnology, Padriciano 99, Trieste, I-34012, Italy.

出版信息

Virology. 2000 Oct 25;276(2):388-94. doi: 10.1006/viro.2000.0514.

DOI:10.1006/viro.2000.0514
PMID:11040129
Abstract

The human papillomavirus type 16 encodes two principal oncoproteins, E6 and E7. The E7 protein has been shown to deregulate the cell cycle through interactions with a variety of proteins involved in cell cycle control and transcriptional regulation. These activities result in E7 being able to cooperate with activated oncogenes in the transformation of primary rodent cells, and with the viral E6 protein during human keratinocyte immortalization. Although a large number of activities have been ascribed to the E7 protein, little is known about its regulation during the cell cycle. We have performed a series of studies to investigate potential changes in E7 phosphorylation during the cell cycle and we show that E7 is indeed differentially phosphorylated. Casein kinase II is the principal kinase during the early part of the cell cycle, but this activity decreases rapidly as cells progress toward S phase. In addition, E7 is transiently phosphorylated at Ser71 in S phase by another, as yet unknown, kinase. These results demonstrate differential regulation of the E7 protein during the cell cycle that most likely represents a means of providing specificity to E7's activities.

摘要

相似文献

1
Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle.
Virology. 2000 Oct 25;276(2):388-94. doi: 10.1006/viro.2000.0514.
2
Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.人乳头瘤病毒16型E7蛋白抑制TATA结合转录因子的DNA相互作用。
J Cell Biochem. 2002;85(4):663-9. doi: 10.1002/jcb.10172.
3
The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.人乳头瘤病毒16型的E7蛋白被酪蛋白激酶II磷酸化。
New Biol. 1989 Oct;1(1):44-53.
4
HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.酪蛋白激酶II磷酸化增强了人乳头瘤病毒16型E7和腺病毒E1a与TATA框结合蛋白的复合物形成。
Oncogene. 1996 Jun 6;12(11):2325-30.
5
Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.人乳头瘤病毒16型E7癌蛋白与腺相关病毒Rep78主要调节蛋白在体外和酵母中的结合以及下游效应的可能性。
J Hum Virol. 2000 May-Jun;3(3):113-24.
6
Repression of p53 transcriptional activity by the HPV E7 proteins.人乳头瘤病毒E7蛋白对p53转录活性的抑制作用。
Virology. 1997 Jan 6;227(1):255-9. doi: 10.1006/viro.1996.8315.
7
Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.由人乳头瘤病毒16型E6和E7永生化的人口腔上皮细胞中细胞周期调节蛋白的改变
Int J Oral Maxillofac Surg. 2006 Jul;35(7):653-7. doi: 10.1016/j.ijom.2006.01.017. Epub 2006 Feb 28.
8
Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.人乳头瘤病毒18型E7蛋白的酪蛋白激酶II磷酸化对于促进进入S期至关重要。
Cell Growth Differ. 2000 Aug;11(8):425-35.
9
E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells.人乳头瘤病毒16型的E6/E7蛋白与表皮生长因子受体-2协同作用,诱导原代正常口腔上皮细胞发生肿瘤转化。
Oncogene. 2004 Jan 15;23(2):350-8. doi: 10.1038/sj.onc.1207148.
10
The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.人乳头瘤病毒16型E6和E7癌蛋白可分别诱导染色体数目和结构的不稳定性。
Cancer Res. 2002 Dec 1;62(23):7075-82.

引用本文的文献

1
Nucleic acid nanobiosystems for cancer theranostics: an overview of emerging trends and challenges.用于癌症诊疗的核酸纳米生物系统:新兴趋势与挑战综述
Nanomedicine (Lond). 2025 Jun;20(11):1281-1298. doi: 10.1080/17435889.2025.2501919. Epub 2025 May 6.
2
Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer.激活 STING/TBK1 通过降解宫颈癌中的 HPV16/18 E7 癌蛋白抑制肿瘤生长。
Cell Death Differ. 2024 Jan;31(1):78-89. doi: 10.1038/s41418-023-01242-w. Epub 2023 Nov 25.
3
Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.
高危型 HPV E7 CKII 磷酸化受体位点对极性蛋白表达的新作用。
BMC Cancer. 2022 Sep 25;22(1):1015. doi: 10.1186/s12885-022-10105-5.
4
CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells.CIGB - 300肽靶向人乳头瘤病毒E7上的CK2磷酸化受体结构域,并破坏宫颈癌细胞中的视网膜母细胞瘤(RB)复合物。
Viruses. 2022 Jul 30;14(8):1681. doi: 10.3390/v14081681.
5
The Activity of L. Latex and Its Components on HPV Reveal Insights into the Antiviral Molecular Mechanism.乳胶及其成分对 HPV 的作用揭示了抗病毒分子机制的新见解。
Int J Mol Sci. 2022 Aug 17;23(16):9241. doi: 10.3390/ijms23169241.
6
Focus on HPV Infection and the Molecular Mechanisms of Oral Carcinogenesis.关注 HPV 感染与口腔癌发生的分子机制。
Viruses. 2021 Mar 26;13(4):559. doi: 10.3390/v13040559.
7
Human papillomavirus E6 and E7: What remains?人乳头瘤病毒 E6 和 E7:还有什么?
Tumour Virus Res. 2021 Jun;11:200213. doi: 10.1016/j.tvr.2021.200213. Epub 2021 Feb 8.
8
Cancer-type dependent expression of CK2 transcripts.细胞角蛋白2(CK2)转录本的癌症类型依赖性表达。
PLoS One. 2017 Dec 4;12(12):e0188854. doi: 10.1371/journal.pone.0188854. eCollection 2017.
9
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.癌症中的CK2:细胞与生化机制及潜在治疗靶点
Pharmaceuticals (Basel). 2017 Jan 28;10(1):18. doi: 10.3390/ph10010018.
10
The human papillomavirus E7 oncoprotein as a regulator of transcription.人乳头瘤病毒E7癌蛋白作为一种转录调节因子。
Virus Res. 2017 Mar 2;231:56-75. doi: 10.1016/j.virusres.2016.10.017. Epub 2016 Nov 8.